The lack of formal training on substandard and falsified (SF) medical products among pharmacists is a significant problem that needs to be addressed to combat the global health threat represented by SF products. A recent study conducted in Sub-Saharan Africa among 355 pharmacy students shows t hat a dedicated educational Read more…
The UNODC Assessment of Trafficking in Medical Products in the Sahel brought to light a terrible situation of substandard and falsified medicines in the area. While there are no reliable estimates of the overall quantities of medical products that are trafficked in different ways and forms in the Sahel countries, Read more…
On the occasion of the upcoming Global Fund Replenishment drive, taking place in New York city during 19-21 September, Adam Aspinall, Fight the Fakes Alliance Chair wrote an opinion piece for the Health Policy Watch: “Fighting the Scourge of Fake Medicines: Global Fund Replenishment is Moment of Truth.” In it, Read more…
A recent comment written by Oksana Zirka Pyzik (UCL Fight the Fakes academic chapter founder and lead) published by nature reviews highlights how poor-quality or fraudulent medicines are causing extensive humanitarian and economic harm, particularly in Africa. Authors claim these products are a global problem that requires a coordinated cross-border response, including enhanced Read more…
A new study conducted by Vayouly Vidhamaly, Konnie Bellingham, Paul N Newton and Céline Caillet and published in the BMJ Journals shows that substandard and falsified veterinary medicines affect animal health, agricultural production and food security and will influence antimicrobial resistance (AMR) in both animals and humans. According to the authors, Read more…
Image by the Medicine Maker Shabbir Imber Safdar, Partnership for Safe Medicines Executive Director and Fight the Fakes board member, was recently featured in the Medicine Maker online magazine. In his article “Drug Supply Chain Security Act” Shabbir discussed how the US drug supply chain is not immune to falsified medicines Read more…
How misinformation has fuelled the sale of COVID-19 substandard and falsified medical products. A UCL Fight The Fakes lead study written by Oksana Pyzik, Dr. John Hertig, Hoda Kanso, Anika Chamba and Sofia Khan shows there is a strong link between fake news and fake medicines. As waves of COVID-19 continue to threaten public Read more…
Deloitte‘s report calls for international healthcare organizations to promote global standards such as, Fight the Fakes member, GS1 DataMatrix barcode for product identification across the medical supply chain in order to ensure citizens around the world have a speedy, equal, and secure access to COVID-19 vaccines. The report, which follows another publication from Deloitte Read more…
Dangerous fakes – trade in counterfeit goods that pose health, safety and environmental risks A new study, conducted by the EU’s intellectual property office (EUIPO) and the Organisation for Economic Co-operation and Development (OECD), shines the spotlight on the scourge of falsified medicines, which have consequences on people’s health, confidence Read more…
A academic article published in February 2022 by Pierre Saliou, Quentin Duteil, Stanley A. Plotkin and Marc Gentilini discusses the recent but growing phenomenon of fake vaccines trafficking, which represents a severe threat to public health. Authors explain how during the COVID-19 pandemic, anti-COVID vaccines have been a prime target Read more…